Cyprus exported goods worth €4,893.5 million from January to September 2026, 14.8% more than a year earlier, according to provisional figures from the Statistical Service of Cyprus (Cystat) published on 9 November 2026. Imports grew faster in money terms, to €11,757.4 million, and the trade deficit widened to €6,863.9 million.1 2
The two products Cyprus itself makes and sells abroad in the largest amounts, halloumi cheese and pharmaceuticals, did not share in the rise: both were slightly lower in the first eight months than a year before.1 3
September exports nearly doubled, mostly to countries outside the EU
Exports in September 2026 were €939.3 million, against €496.6 million in September 2025, a rise of 89.1%. Imports rose 19.7% to €1,489.6 million.1
Οι εξαγωγές προς άλλα Κράτη Μέλη της ΕΕ ανήλθαν σε €216,0 εκ. και οι εξαγωγές προς τρίτες χώρες σε €723,3 εκ.
Exports to other EU member states came to €216.0 million and exports to third countries to €723.3 million.1
A year earlier the figures were €172.7 million to the EU and €323.9 million to countries outside it. Most of the September increase therefore came from sales outside the EU. Part of it is ships: Cystat counts the transfer of a vessel's economic ownership as an export, and these transfers were worth €157.3 million in September 2026, against €108.0 million a year earlier. That accounts for about €49 million of the rise of almost €400 million in exports to third countries. The release does not say what made up the rest, and the press report of the figures gives no further breakdown.1 2
Cystat records exports to countries outside the EU by their country of final destination. The monthly release gives only the split between EU and non-EU partners; it does not name the United States or any other country.1
Halloumi and medicines lead home-made exports but fell slightly
Leaving aside fuels and supplies to ships and aircraft, the main home-made exports from January to August 2026 were halloumi at €258.3 million, pharmaceutical products at €226.1 million and waste and scrap of paper, glass and metal at €71.1 million.1
For the same eight months of 2025, Cystat's release of November 2025, as reported in the Cypriot press, gave halloumi at €262.9 million and pharmaceuticals at €228.9 million. On those published figures halloumi was down about 1.7% and pharmaceuticals about 1.2%. This is this site's comparison of two releases a year apart, and Cystat revises earlier months, so the gap may change.1 3
August's final figures show the wider picture for goods made on the island. Domestic exports rose 29.8% to €518.5 million, but most of that category is fuels and ship supplies. Industrial goods outside fuels rose only from €71.2 million to €73.6 million, and farm products from €6.4 million to €7.0 million. Re-exports of goods made elsewhere fell 14.5% to €125.2 million.1
What US tariffs apply to these goods
Cyprus trades with the United States as part of the European Union, and its goods face the US tariffs set for the EU. Under the forced-labour tariffs that the United States imposed on 60 economies under Section 301 of the Trade Act of 1974, the law that lets the US Trade Representative act against foreign practices it judges unfair, EU goods have paid 10% net of the ordinary duty since 24 July 2026, according to the independent tracker Global Trade Alert. Goods covered by Section 232 tariffs, imposed on national-security grounds, are excluded.4
Medicines fall under Section 232. Proclamation 11020 of April 2026 sets the rate on patented pharmaceuticals at 15% for products of the European Union, applied from 31 July 2026 to named companies and from 29 September 2026 to all others. Generic medicines "shall not be subject to tariffs pursuant to section 232 at this time", the proclamation says.5 4
The Cystat release does not show how much of Cyprus's halloumi or medicine went to the United States, so the figures do not show whether these tariffs played any part in the small decline. Exports by destination country are published in Cystat's database rather than in the monthly release, and the next monthly release, with provisional figures for October, will show whether the gap in halloumi and medicine sales has closed by the end of the year.1